At a reconstituted concentration of 2mg/mL (with 2.5mL BAC water), each 5mg vial provides 5 x 1mg doses or 25 x 0.2mg doses
Some preclinical data suggests BPC-157 demonstrates oral bioavailability, but direct comparisons between injectable study protocols and oral supplementation in humans have not been established through clinical research
HPLC purity assay Mass-spec identity Measured content 48.74mg Test date 28/05/2026 Current batch NVCU50-01052026 Method HPLC LC-MS Certificate of Analysis available Download or independently verify the full third-party report for this peptide
A local injection-site reaction Intramuscular injections can leave the area sore, red, warm or slightly swollen for a day or two
This specialized configuration is engineered strictly for investigating parallel extracellular matrix remodeling, accelerated angiogenesis, and cellular resilience pathways
Rotate injection sites (abdomen, thighs, upper arms) at least 1 inch apart